The ROADSTER 2 Study evaluated real-world usage of the ENROUTE® Transcarotid Stent System in conjunction with the ENROUTE® Transcarotid Neuroprotection System in high surgical risk patients with carotid artery stenosis. 632 patients were treated across 42 sites, with 80% of the physician enrollers being new TCAR operators.
ROADSTER 2: Trial Results – FDA Analysis Population
– Vikram Kashyap & Peter Schneider on behalf of the ROADSTER 2 investigators – SVS VAM Presentation, June 2019
“The learning curve is short and steep, as people get good within five cases or so, and are able to get outstanding outcomes.”
– Vikram Kashyap, MD – University Hospitals Case Medical Center, Cleveland OH